Advanced lipid-lowering therapies are reshaping the hyperlipidemia drug market as clinicians treat high-risk patients who may not achieve adequate cholesterol reduction with conventional oral therapies alone. PCSK9 inhibitors, small-interfering RNA treatments, and other non-statin medicines are creating new therapeutic pathways.marketresearchfuture
PCSK9 inhibitors are the fastest-growing drug...
Asia-Pacific is becoming an increasingly important region in the anti aging supplement market as rising incomes, urbanization, digital commerce, beauty culture, and preventive-health awareness increase demand. The region accounts for about 20% of global market share and is expected to continue expanding.
China, Japan, South Korea, India, and Southeast Asian countries are...